More Globe Newswire

View Older Stories View Newer Stories

Sep 8, 2026 07:00AM Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer
Sep 8, 2026 07:00AM Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
Sep 8, 2026 07:00AM NetraMark Appoints Former Global Atlantic Investment Office President and Scotiabank U.S. CEO Kevin Felix as Strategic Advisor
Sep 8, 2026 07:00AM BrewDog Roars into Rugby with Five-Year Leicester Tigers Partnership, Bringing Punk Energy to Welford Road
Sep 8, 2026 07:00AM Erasca to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
Sep 8, 2026 07:00AM OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference
Sep 8, 2026 07:00AM Beamr and VAST Data Partner to AI-enhance and Monetize Video Archives with NVIDIA
Sep 8, 2026 07:00AM Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
Sep 8, 2026 07:00AM NRx Pharmaceuticals to Participate in Upcoming Investor Conferences
Sep 8, 2026 07:00AM DraftKings Extends Agreement with IC360 to Enhance Integrity Monitoring and Combat Athlete Harassment Across Sportsbook and Prediction Market Platforms
Sep 8, 2026 07:00AM Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer
Sep 8, 2026 07:00AM Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC
Sep 8, 2026 07:00AM Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)
Sep 8, 2026 07:00AM LiveU, AP bring new connectivity, workflow tech to global newsgathering, deploying largest LU900Q fleet worldwide
Sep 8, 2026 07:00AM Cloverleaf Bio Raises $33 Million Seed Financing to Advance Novel RNA-Based Cancer Therapeutics
Sep 8, 2026 07:00AM Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development
Sep 8, 2026 07:00AM CoinShares Co-Founder and Non-Executive Director Daniel Masters Adopts Pre-Scheduled Trading Plan
Sep 8, 2026 06:58AM ABM Reports Fiscal Third Quarter 2026 Results
Sep 8, 2026 06:55AM YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
Sep 8, 2026 06:55AM YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs
Sep 8, 2026 06:50AM Treno Scope Launches Liquidity Analysis Module, with Initial Focus on the Indonesian Market
Sep 8, 2026 06:50AM Pharvaris Announces Positive Topline Data from CHAPTER-3 Pivotal Study of Deucrictibant XR for Prophylaxis of HAE Attacks
Sep 8, 2026 06:45AM Bullish releases August 2026 monthly metrics
Sep 8, 2026 06:42AM 2026 CIFTIS Culture and Tourism Services Section Media Briefing Held in Beijing
Sep 8, 2026 06:30AM DPM Metals Extends Mineralization at Dumitru Potok with High-Grade Intercepts
Sep 8, 2026 06:30AM Zacatecas Silver Announces Multiple Silver Assays from El Cristo Drill Program
Sep 8, 2026 06:30AM Nova Minerals’ Marches towards Antimony Production with Arrival of Processing & Refining Equipment in Alaska
Sep 8, 2026 06:30AM Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets
Sep 8, 2026 06:30AM Four Rigs Now Turning at Pecoy
Sep 8, 2026 06:30AM UK’s MHRA Accepts Biosplice’s Application for Lorecivivint (LOR) in Knee Osteoarthritis and Begins Assessment
Sep 8, 2026 06:30AM Prana Therapies Announces Positive Phase 1 Results for PRA-216, a Novel IL-4Rα/TSLP Bispecific Antibody, Supporting Its Potential Best-in-Disease Profile and Providing the First Clinical Validation o
Sep 8, 2026 06:30AM Nova Minerals’ Marches towards Antimony Production with Arrival of Processing & Refining Equipment in Alaska
Sep 8, 2026 06:30AM FTC Solar to Participate in Upcoming Investor Events
Sep 8, 2026 06:30AM Vitaquest International Appoints Luigi Cappello as Chief Commercial Officer
Sep 8, 2026 06:26AM La Mancha Investments S. à r. l. to File Early Warning Report
Sep 8, 2026 06:18AM OneMetric Selected by HubSpot to Present Agentic Solution at UNBOUND 2026
Sep 8, 2026 06:14AM Holtec Nuclear Corporation Announces Launch of Initial Public Offering
Sep 8, 2026 06:11AM Form 8.3 - Gamma Communications Plc
Sep 8, 2026 06:00AM Vaisala launches Care services to help data centers maintain measurement accuracy at scale
Sep 8, 2026 06:00AM Liberty Gold Announces Black Pine Feasibility Study with US$2.4 Billion NPV(5%) and 60% IRR at $3,250/oz Au (after-tax)
Sep 8, 2026 06:00AM Alex Kurland Joins Menlo Ventures as Partner
Sep 8, 2026 06:00AM MEXC Launches “Trade Wall Street Without Walls” to Break Traditional Barriers to Stock Market Participation
Sep 8, 2026 06:00AM MEXC Launches Opportunity Compass as 53.7% of Crypto Users Move Into Stocks but Knowledge Gaps Remain
Sep 8, 2026 06:00AM Arab Global Crypto Exchange (AGCX) to Launch on September 10 with AED Support and Zero Platform Fees on Crypto Transfers
Sep 8, 2026 06:00AM Holtec Nuclear Corporation Awarded Contract to Continue Supply of Additional Spent Fuel Storage Systems for Ukraine VVER Reactors
Sep 8, 2026 06:00AM NVRO Metals Announces Planned Management and Board Transition
Sep 8, 2026 06:00AM RadNet, Inc. to Present at the Jefferies Healthcare Services and Technology Conference on September 15, 2026
Sep 8, 2026 06:00AM AsiaStrategy Expands Bitcoin-Backed Pledging Business with New Institutional Credit Facility
Sep 8, 2026 06:00AM Roivant Announces Positive Results from PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) and Unveils Ongoing Phase 3 PHrontier Stu
Sep 8, 2026 06:00AM Pulmovant Announces Positive Results from PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) and Unveils Ongoing Phase 3 PHrontier S
View Newer Stories View Older Stories